Results 191 to 200 of about 10,148,101 (391)
BackgroundThis study aims to investigate the distribution and drug resistance of Gram-negative bacteria in the intensive care unit (ICU) of a tertiary general hospital in Sichuan Province, with the goal of promoting rational antibiotic use and reducing ...
Xiaoying Chen+4 more
doaj +1 more source
Advances in cancer therapy: clinical benefit of new cancer drugs
Daniel Tobias Michaeli+2 more
openalex +1 more source
Speech Disorder, Partial Syndrome of Gilles De La Tourette, and Drug Therapy [PDF]
Ian B. Cookson
openalex +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
PD-L2 Expression in Breast Cancer Promotes Tumor Development and Progression
Background. This work focused on investigating the role of programmed death ligand 2 (PD-L2) in the progression of breast cancer by utilizing breast cancer specimens and cells. Materials and Methods.
Yuling Sun+10 more
doaj +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy [PDF]
Joan M. Bull+7 more
openalex +1 more source